Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia
FranceStudy of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
FranceStudy of sotorasib with chemotherapy combination for adult patients with advanced pancreatic cancer who have KRAS p.
FranceStudy on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride
FranceStudy on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy on Tislelizumab for Elderly Patients with Advanced Esophageal Squamous Cell Carcinoma Unfit for Chemotherapy
FranceStudy on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome
FranceStudy of Tarlatamab for Patients with Metastatic or Advanced Small-Cell Lung Cancer and Neuroendocrine Carcinomas
FranceStudy of mRNA-4157 and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
FranceStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
FranceStudy of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns
FranceStudy on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
